The Federal Reserve will keep interest rates steady through the first half of the year, before delivering two reductions ...

Independent Advisor Alliance lessened its stake in Kinsale Capital Group, Inc. (NYSE:KNSL – Free Report) by 3.7% during the ...

BMO Capital Markets upgraded shares of goeasy (TSE:GSY – Free Report) from a market perform rating to an outperform rating in ...

The global silver market is under stress as trade-war concerns unsettle investors, with key indicators flashing red, millions ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...

Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.

ECN Capital Corp. (TSX: ECN) ("ECN Capital” or the "Company”) today announced that it has entered into an agreement with a syndicate of underwriters (the "Underwriters”) led by CIBC Capital Markets, ...

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...

Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney ...

On Tuesday, BMO Capital Markets began coverage of Avidity Biosciences (NASDAQ:RNA) shares, assigning an Outperform rating and setting a price target of $72.00. Currently trading at $29.58, the stock ...